PMLive21h
World Kidney Day – Boehringer launches CKD initiative to tackle UK health inequalities
This World Kidney Day (13 March 2025), Boehringer Ingelheim (BI) has announced a new initiative aimed at detecting, ...
PMLive21h
Biogen initiates phase 3 study of felzartamab in kidney transplant patients
Beyond AMR, Biogen is planning to initiate phase 3 trials of felzartamab in two kidney diseases, IgA nephropathy and primary ...
PMLive21h
NICE recommends Gideon Richter’s Ryeqo as first daily pill for endometriosis
The National Institute for Health and Care Excellence (NICE) has recommended Gideon Richter’s Ryeqo (relugolix, estradiol and ...